Literature DB >> 9563732

Determinants of aerobic and anaerobic exercise performance in cystic fibrosis.

A R Shah1, D Gozal, T G Keens.   

Abstract

We examined aerobic and anaerobic exercise performance in 17 subjects with cystic fibrosis (CF) (age 25+/-10 [SD] yr; 47% females; FEV1 62+/-21% pred) and 17 age- and sex-matched control subjects (age 25+/-8 [SD] yr; 41% females; FEV1 112+/-15% pred) in relation to pulmonary function and nutritional status. Aerobic capacity was determined as maximal oxygen consumption (VO2max) (ml/kg/min) and anaerobic threshold (AT; ml VO2/kg/min) from a graded exercise stress test on an electronically braked bicycle ergometer. Anaerobic performance was assessed from the average work of two bouts of pedaling to exhaustion at a load corresponding to 130% Vo2max from graded exercise. Both aerobic and anaerobic performances were decreased in subjects with CF (p < 0.001). The duration of anaerobic exercise in subjects with CF was similar to control subjects. In control subjects, pulmonary function did not correlate to aerobic or anaerobic exercise. In subjects with CF significant relationships between FEV1, vital capacity, and FEF25-75% to AT were found, suggesting the pulmonary limitation to aerobic capacity. In both patients with CF and control subjects, lean body mass and arm muscle area significantly correlated with anaerobic performance but not with VO2max or AT. We conclude that nutritional status, rather than pulmonary function, is the major determinant of anaerobic exercise capacity in CF. The preserved duration of anaerobic exercise at equivalent workloads (corresponding to 130% of VO2max from graded exercise) suggests that readily available energy stores in muscle may be similar in CF and normal individuals.

Entities:  

Mesh:

Year:  1998        PMID: 9563732     DOI: 10.1164/ajrccm.157.4.9705023

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Overall and differentiated sensory responses to cardiopulmonary exercise test in patients with cystic fibrosis: kinetics and ability to predict peak oxygen uptake.

Authors:  Mathieu Gruet; Laurent Mely; Jean-Marc Vallier
Journal:  Eur J Appl Physiol       Date:  2018-07-09       Impact factor: 3.078

2.  Exercise training in children and adolescents with cystic fibrosis: theory into practice.

Authors:  Craig A Williams; Christian Benden; Daniel Stevens; Thomas Radtke
Journal:  Int J Pediatr       Date:  2010-09-19

Review 3.  Growth hormone and exercise tolerance in patients with cystic fibrosis.

Authors:  Matthias Hütler; Ralph Beneke
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  Reduced anaerobic and aerobic performance in children with primary ciliary dyskinesia.

Authors:  Senem Simsek; Deniz Inal-Ince; Aslihan Cakmak; Nagehan Emiralioglu; Ebru Calik-Kutukcu; Melda Saglam; Naciye Vardar-Yagli; Hayriye Ugur Ozcelik; Hazal Sonbahar-Ulu; Cemile Bozdemir-Ozel; Nural Kiper; Hulya Arikan
Journal:  Eur J Pediatr       Date:  2018-02-27       Impact factor: 3.183

5.  Ventilatory response to exercise in adolescents with cystic fibrosis and mild-to-moderate airway obstruction.

Authors:  Bart C Bongers; Maarten S Werkman; Tim Takken; Erik H J Hulzebos
Journal:  Springerplus       Date:  2014-11-27

6.  High-intensity interval training accelerates oxygen uptake kinetics and improves exercise tolerance for individuals with cystic fibrosis.

Authors:  Ronen Reuveny; Fred J DiMenna; Cedric Gunaratnam; Avigdor D Arad; Gerry N McElvaney; Davide Susta; Michael Peled; Niall M Moyna
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-04-13

7.  The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis: A Case Control Study.

Authors:  Katerina Manika; Georgia G Pitsiou; Afroditi K Boutou; Vassilis Tsaoussis; Nikolaos Chavouzis; Marina Antoniou; Maria Fotoulaki; Ioannis Stanopoulos; Ioannis Kioumis
Journal:  Pulm Med       Date:  2012-07-29

Review 8.  Infection, inflammation and exercise in cystic fibrosis.

Authors:  Pauline Barbera van de Weert-van Leeuwen; Hubertus Gerardus Maria Arets; Cornelis Korstiaan van der Ent; Jeffrey Matthijn Beekman
Journal:  Respir Res       Date:  2013-03-06

9.  Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease.

Authors:  Jean Pastré; Anne Prévotat; Catherine Tardif; Carole Langlois; Alain Duhamel; Benoit Wallaert
Journal:  BMC Pulm Med       Date:  2014-04-30       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.